Characteristics and patient-reported outcomes of long-term cancer survivors after apatinib-based therapy: an online survey-Reference-Cited by-同舟云学术

Characteristics and patient-reported outcomes of long-term cancer survivors after apatinib-based therapy: an online survey

Published:2024-08-31 Issue:1 Volume:24 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Zhang Tingting,Meng Chao,He Wei,Xu Tao,Yang Yi,Tu Chongqi,Zhang Ling,Sun Xiaofeng,Zhu Chunrong,Dang Xueyi,Wang Ke,Chen Chuan,Yan Xiong,Xu Huiting,Huang Le,Jiang Enlai,Xia Feng,Zhou Xinming,Zhou Shunkai,Zang Weidong,Li Xifeng,Zhang Jin,Zheng Jiaping,Xin Jianjun,Huang Bin,Zhu Guopei,Zhu Jiexiang,Liang Jun

Funder

Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12885-024-12832-3.pdf

Reference22 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.

2. Coleman MP, Quaresma M, Berrino F, Lutz J-M, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9(8):730–56.

3. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang X-S, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, et al. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972):977–1010.

4. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.

5. Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TML, Myklebust TÅ, Tervonen H, Thursfield V, Ransom D, Shack L, et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20(11):1493–505.